The evolution and clinical impact of human leukocyte antigen technology

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 6, 2010, Pages 598-602

  Gebel, Howard M ^a   Bray, Robert A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

calculated panel reactive antibodies; human leukocyte antibodies; human leukocyte antigens; virtual crossmatch

Indexed keywords

HLA ANTIGEN; HLA CW ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; PANEL REACTIVE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; CLASSIFICATION ALGORITHM; HISTOCOMPATIBILITY TEST; HLA TYPING; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SENSITIZATION;

ANTIBODIES; DONOR SELECTION; GRAFT REJECTION; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS;

EID: 77958527497     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32833dfc3f     Document Type: Review

References (36)

1. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280:735-739.
2. Terasaki PI. Humoral theory of transplantation. Am J Transpl 2003; 3:665-673.
3. Bray RA, Nickerson PW, Kerman RH, Gebel HM. Evolution of HLA antibody detection: technology emulating biology. Immunol Res 2004; 29:41-53.
4. Gebel HM, Bray RA, Nickerson PW. Pretransplant assessment of donor-reactive, HLA specific antibodies in renal transplantation: contraindication vs risk. Am J Transplant 2003; 3:1488-1500.
5. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA Class I and Class II antibodies screening with flow cytometry. Hum Immunol 1998; 5:313-322.
6. Pei R, Lee J-H, Shih N-J, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antibody specificities. Transplantation 2003; 75:43-49.
7. Welsh K, Bunce M. Molecular typing for the MHC with PCR-SSP. Rev Immunogenet 1999; 1:157-176.
8. Tiercy JM, Jeannet M, Mach B. A new approach for the analysis of HLA class II polymorphism: 'HLA oligotyping'. Blood Rev 1990; 4:9-15.
9. Bray RA, Nolen JDL, Larsen C, et al. Transplanting the highly sensitized patient: the Emory Algorithm. Am J Transplant 2006; 6:2307-2315.
10. Bingaman AW, Murphey CL, Palma-Vargas J, Wright F. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 2008; 86:1864-1868.
11. UNOS rationale for objectives of equitable organ allocation. Richmond, VA: United Network for Organ Sharing; 1994. http://www.unos.org/resources/ bioethics.asp?index=8.
12. Cecka JM. Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant 2010; 10:26-29.
13. Organ and Transplantation Network. Organ distribution: Allocation of deceased kidneys. http://www.optn.transplant.hrsa.gov/PoliciesandBylaws2/ policies/pdfs/policy-7.pdf-2009-10-12.
14. Zachary AZ, Sholander TJ, Houp JA, Leffell MS. Using real data for a virtual crossmatch. Hum Immunol 2009; 70:574-579.
15. Amico P, Honger G, Steiger J, Schaub S. Utility of the virtual crossmatch in solid organ transplantation. CurrOpin Organ Transplant 2009; 14:656-661.
16. Tambur AR, Ramon DS, Kaufman DB, et al. Perception versus reality? Virtual crossmatch-how to overcome some of the technical and logistic limitations. Am J Transplant 2009; 9:1886-1893.
17. Bryan CF, Luger AM, Smith JL, et al. Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. Clin Transplant 2010; 24:56-61.
18. Billen EV, Christiaans MH, Doxiadis II, et al. HLA-DP antibodies before and after renal transplantation. Tissue Antigens 2010; 75:278-285.
19. Cano P, Fernandez-Vina M. Two sequence dimorphisms of DPB1 define the immunodominant serologic epitopes of HLA-DP. Hum Immunol 2009; 10:836-843.
20. Barabanova Y, Ramon DS, Tambur AR. Antibodies against HLA-DQ alpha-chain and their role in organ transplantation. Hum Immunol 2009; 70:410-412.
21. Deng CT, El-Awar N, Ozawa M, et al. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients. Transplantation 2008; 86:452-459.
22. Nikaein A, Cherikh W, Nelson K, et al. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee col laborative study to evaluate prediction of crossmatch results in highly sensi tized patients. Transplantation 2009; 87:557-562.
23. Vlad G, Ho EK, Vasilescu ER, et al. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol 2009; 70:589-594.
24. Bielmann D, Honger G, Lutz D, et al. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 2007; 7:626-632.
25. Patel AM, Pancoska C, Mulgaonkar S, Weng FL. Renal transplantation in patients with pretransplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 2007; 7:2371-2377.
26. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 2008; 8:324-331.
27. Dunn TB, Ozturk OG, Noreen H, et al. Impact of flow XM results on kidney transplant outcomes for recipients with donor specific antibody (DSA). Am J Transplant 2010; 10 (Suppl 4):236.
28. Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant 2010; 10:449-457.
29. Vo AA, Peng A, Toyoda M, et al. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation. Transplantation 2010; 89:1095-1102.
30. Everly JJ, Walsh RC, Alloway RR, Woodle ES. Proteasome inhibition for antibody-mediated rejection. Curr Opin Organ Transplant 2009; 14:662-666.
31. Lynch RJ, Platt JL. Escaping from rejection. Transplantation 2009; 88:1233-1236.
32. Gloor JM, Winters JL, Cornell LD, et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010; 10:582-589.
33. Segev DL, Gentry SE, Warren DS, et al. Kidney paired donation and optimizing the use of live donor organs. JAMA 2005; 293:1883-1890.
34. Hanto RL, Reitsma W, Delmonico FL. The development of a successful multiregional kidney paired donation program. Transplantation 2008; 86: 1744-1748.
35. Rees MA, Kopke JE, Pelletier RP, et al. A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med 2009; 360:1096-1101.
36. Gebel HM, Moussa O, Eckels DD, Bray RA. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums. Hum Immunol 2009; 70:610-617.